Phase I/II Evaluation of Intraoperative Autotransfusion Filtration for Major Surgical Oncology Operations

Trial Information

Phase I/II Evaluation of Intraoperative Autotransfusion Filtration for Major Surgical Oncology Operations

Homologous blood transfusions during surgical procedures are becoming more challenging, due
to lack of adequate reserves and the significant risks of transfusion reactions. Recent
advances in the use of patient's own blood (autologous transfusion) has rapidly gained
acceptance in major surgical procedures, however due to the requirement for prior planning
and the expense of obtaining and storing a patient's blood prior to surgery this alternative
is less than ideal.

This research study utilizes a third alternative, a technique called intraoperative
autotransfusion, which successfully salvages a patient's blood during surgery and reinfuses
the blood back into the patient. The blood salvaging device uses a filtration device that
successfully filters out all tumor cells to prevent re-infusion of viable cancer cells.

This study is designed to demonstrate the safety and benefits of the blood salvaging device
on patients undergoing major surgical oncology procedures.